Featured News
714Wire StoriesWipro’s Annual State of Cybersecurity Report Finds Increasing Adoption of AI in Cybersecurity to Tackle Advanced Adversaries
Nearly half (49%) of organizations plan to extend Cognitive and AI capabilities for security to detect and respond to attacks faster EAST...
- 875News
Michael Terence Publishing Announce the Release of “Sonny’s Circus Dream” by Jen Malone
Michael Terence Publishing is excited to announce the release of Sonny’s Circus Dream – a children’s book written by Jen Malone and...
- 674News
Preemie System Wins German Design Award for Its Preemie Sensor in the Category of Medical, Rehabilitation and Health Care
Preemie sensor is a small, portable device created for neonatologists, nurses, and human milk bank professionals to analyse milk for its nutritional...
- 724Wire Stories
FluroTech Announces Stadium and Arena Product Solution
CALGARY, Alberta, Nov. 17, 2020 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that...
- 684Wire Stories
Global Smart TV Market 2020-2024: Market Analysis, Drivers, Restraints, Opportunities, and Threats – Technavio
LONDON–(BUSINESS WIRE)–#GlobalSmartTVMarket–The smart tv market is expected to grow by 293.32 million units, progressing at a CAGR of over 21% during the...
- 702Wire Stories
C.H. Robinson Uncovers More Than a Billion Dollars in Tariff Refunds Going Untapped
Companies big and small are running out of time to collect Chinese tariff relief with nearing deadline EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Global logistics...
- 689Wire Stories
Flashpoint Acquires CRFT to Bring No-Code Automation to Threat Intelligence
Ushers in New Era of Event-Driven Intelligence for CTI, Fraud, and Security Teams NEW YORK–(BUSINESS WIRE)–Flashpoint, the globally trusted leader in actionable...
- 722Wire Stories
Aquila Resources Submits Dam Safety Permit Application for Its Back Forty Project
TORONTO–(BUSINESS WIRE)–Aquila Resources Inc. (TSX: AQA, OTCQB: AQARF) (“Aquila” or the “Company”) is pleased to announce that it has applied to the...
- 740Wire Stories
D3 Bio Launches with US$200 Million Investment to Develop Precision Medicines Addressing Unmet Patient Needs in Oncology & Immunology
Global biotech headed by seasoned industry veterans secures backing from world-class investor syndicate Novel approach to guided drug development utilizes clinical and...
- 688Wire Stories
Global Bubble Tea Brand Investing Aggressively in North America Expansion
Gong cha seeking franchisees in the U.S. BOSTON–(BUSINESS WIRE)–Gong cha, one of the world’s most recognized Taiwanese tea brands, today announced that...
- 903Wire Stories
BeiGene Announces that RATIONALE 303 Trial of Tislelizumab in Non-Small Cell Lung Cancer Met the Primary Endpoint of Overall Survival at Interim Analysis
RATIONALE 303 is a global Phase 3 trial of BeiGene’s anti-PD-1 antibody tislelizumab compared to docetaxel in the second- or third-line setting...
